Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:LMNL

Liminal BioSciences (LMNL) Stock Price, News & Analysis

Liminal BioSciences logo

About Liminal BioSciences Stock (NASDAQ:LMNL)

Advanced Chart

Key Stats

Today's Range
$8.50
$8.50
50-Day Range
$8.38
$8.50
52-Week Range
$3.10
$8.50
Volume
N/A
Average Volume
63,470 shs
Market Capitalization
$26.35 million
P/E Ratio
29.31
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive LMNL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Liminal BioSciences and its competitors with MarketBeat's FREE daily newsletter.

LMNL Stock News Headlines

Trump’s biggest move, misreported
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.
See More Headlines

LMNL Stock Analysis - Frequently Asked Questions

Liminal BioSciences Inc. (NASDAQ:LMNL) posted its quarterly earnings results on Monday, November, 15th. The company reported $27.40 earnings per share for the quarter, beating analysts' consensus estimates of ($2.80) by $30.20. The company had revenue of $0.14 million for the quarter, compared to the consensus estimate of $0.02 million. Liminal BioSciences had a net margin of 248.35% and a negative trailing twelve-month return on equity of 88.44%.

Shares of Liminal BioSciences reverse split on Wednesday, February 1st 2023.The 1-10 reverse split was announced on Wednesday, February 1st 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 1st 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Liminal BioSciences investors own include Corbus Pharmaceuticals (CRBP), Bionano Genomics (BNGO), HubSpot (HUBS), iBio (IBIO), Dynavax Technologies (DVAX), Diamondback Energy (FANG) and NIO (NIO).

Company Calendar

Last Earnings
11/15/2021
Today
7/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:LMNL
CIK
1351172
Employees
251
Year Founded
N/A

Profitability

Trailing P/E Ratio
29.31
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$380 thousand
Pretax Margin
-5,729.40%

Debt

Sales & Book Value

Annual Sales
$310 thousand
Price / Cash Flow
N/A
Book Value
$8.97 per share
Price / Book
0.95

Miscellaneous

Free Float
3,036,000
Market Cap
$26.35 million
Optionable
Not Optionable
Beta
1.03
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:LMNL) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners